Back to Top
Minretumomab Biosimilar - Research Grade
$315.00 - $19,890.00
Minretumomab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Species Reactivity
Human
Target
TAG-72
Concentration
5mg/ml
Isotype
Human IgG1 Kappa
Host
CHO Cells
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Applications
Functional Assays
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Specificity
Detects human TAG-72
Shipping Conditions
Blue ice
Background
Tumour-associated glycoprotein 72 (TAG-72) is a mucin-like antigen over-expressed on many adenocarcinomas and a long-standing marker in tumour-targeting research. This recombinant anti-human TAG-72 monoclonal is an unconjugated, non-therapeutic analog of minretumomab, supplied for research use only (RUO). It is produced to in vivo standards with low endotoxin and offered in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. The reagent supports functional assays, tumour-cell binding and imaging-development studies, reproducible controls, and in vivo carcinoma models, providing the lot-to-lot consistency that heavy-usage and high-throughput tumour-targeting work depends on.
Buffer
ICH3002
Sequence
https://www.imgt.org/mAb-DB/
Write Your Own Review


















